Prostate cancer hormone therapy hard on the heart

Men with recurrent or advanced prostate cancer may be put on hormone therapy to block testosterone production in an effort to halt or slow the growth of the tumor. However, new research shows, this may put them at increased risk for developing insulin resistance and elevated blood sugar levels, which can affect heart health.

These complications of what doctors call androgen-deprivation therapy or ADT may contribute to the high rate of heart disease in men with prostate cancer, Baltimore-based investigators report in the journal Cancer.

Roughly half of men who develop prostate cancer die of other, unrelated causes, explain Dr. Shehzad Basaria from Johns Hopkins University and colleagues. Heart disease is one of the most common causes of death in men with prostate cancer.

In a study of 53 men with prostate cancer, the researchers found that those treated with testosterone-lowering ADT for at least one year were more resistant to the action of insulin - the body’s key sugar-regulating hormone - and had higher glucose levels than men who had only received local surgery and/or radiation and had normal testosterone levels, and age-matched healthy men with normal testosterone levels.

According to the study, 44 percent of men in the ADT group had blood sugar levels greater than 126, which is among the criteria for the diagnosis of diabetes. In contrast, only about 12 percent of men in the other groups had blood sugar levels this high.

In an e-mail to Reuters Health, Basaria said: “If these observations are confirmed in long-term prospective studies, then insulin resistance and diabetes should be regarded as additional side effects of androgen deprivation in these men.”

In the meantime, the investigators think men with prostate cancer who have received ADT for at least one year should be screened for high blood sugar.

More study, they add, is needed to determine the value of anti-diabetes drugs in men with prostate cancer.

SOURCE: Cancer, February 1, 2006.

RELATED STORIES:
Cancer in sister affects black men’s cancer risk   Acrylamide in food not linked to prostate cancer   Surgeon’s skill affects prostate cancer relapse   Prostate cancer diagnosis raises risk of suicide   “Watchful waiting” safe for some prostate cancers   Researchers identify promising cancer drug target in prostate tumors   Drug Attacks Prostate Cancer in Mouse Model by Destroying Its Blood Supply   Prostate cancer spurs new nerves   Prostate cancer treatment choices vary based on type of specialist consulted   Red Wine Compound Shown To Prevent Prostate Cancer   Link Uncovered Between Benign Prostatic Hyperplasia, NSAIDs   Soya products, beans and sunflower seeds reduce risk of contracting prostate cancer   Why Prostate Cancer Patients Fail Hormone Deprivation   Why a common treatment for prostate cancer ultimately fails   Daily drinking may raise risk of several cancers   Vaccine Approach Extends Life of Metastatic Prostate Cancer Patients   PSA retesting interval can be individualized   Fatherhood linked to prostate cancer risk   Younger men with advanced prostate cancer have shorter survival times   Alternative therapy common in prostate cancer   Prostate test ‘public health disaster’ - discoverer   PSA levels accurately predict prostate cancer risk in African-American men

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]